| Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies A Mandal, R Bisht, ID Rupenthal, AK Mitra Journal of Controlled Release 248, 96-116, 2017 | 429 | 2017 |
| A comprehensive insight on ocular pharmacokinetics V Agrahari, A Mandal, V Agrahari, HM Trinh, M Joseph, A Ray, H Hadji, ... Drug delivery and translational research 6, 735-754, 2016 | 392 | 2016 |
| Hydrogels in the clinic A Mandal, JR Clegg, AC Anselmo, S Mitragotri Bioengineering & translational medicine 5 (2), e10158, 2020 | 326 | 2020 |
| Ocular delivery of proteins and peptides: Challenges and novel formulation approaches A Mandal, D Pal, V Agrahari, HM Trinh, M Joseph, AK Mitra Advanced drug delivery reviews 126, 67-95, 2018 | 200 | 2018 |
| Novel delivery approaches for cancer therapeutics AK Mitra, V Agrahari, A Mandal, K Cholkar, C Natarajan, S Shah, ... Journal of controlled release 219, 248-268, 2015 | 190 | 2015 |
| Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases R Bisht, A Mandal, JK Jaiswal, ID Rupenthal Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 10 (2 …, 2018 | 134 | 2018 |
| Ocular pharmacokinetics of a topical ophthalmic nanomicellar solution of cyclosporine (Cequa®) for dry eye disease A Mandal, V Gote, D Pal, A Ogundele, AK Mitra Pharmaceutical research 36, 1-21, 2019 | 125 | 2019 |
| Erythrocyte-driven immunization via biomimicry of their natural antigen-presenting function A Ukidve, Z Zhao, A Fehnel, V Krishnan, DC Pan, Y Gao, A Mandal, ... Proceedings of the National Academy of Sciences 117 (30), 17727-17736, 2020 | 86 | 2020 |
| Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases Z Zhao, A Ukidve, V Krishnan, A Fehnel, DC Pan, Y Gao, J Kim, MA Evans, ... Nature Biomedical Engineering 5 (5), 441-454, 2021 | 68 | 2021 |
| Topical delivery of siRNA into skin using ionic liquids V Dharamdasani, A Mandal, QM Qi, I Suzuki, MVLB Bentley, S Mitragotri Journal of Controlled Release 323, 475-482, 2020 | 66 | 2020 |
| Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations A Mandal, N Kumbhojkar, C Reilly, V Dharamdasani, A Ukidve, DE Ingber, ... Science advances 6 (30), eabb6049, 2020 | 63 | 2020 |
| Topical formulation of self-assembled antiviral prodrug nanomicelles for targeted retinal delivery A Mandal, K Cholkar, V Khurana, A Shah, V Agrahari, R Bisht, D Pal, ... Molecular pharmaceutics 14 (6), 2056-2069, 2017 | 60 | 2017 |
| How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches V Agrahari, V Agrahari, A Mandal, D Pal, AK Mitra Expert opinion on drug delivery 14 (10), 1145-1162, 2017 | 56 | 2017 |
| Emerging nanotechnologies for diagnostics, drug delivery and medical devices AK Mitra, K Cholkar, A Mandal William Andrew, 2017 | 55 | 2017 |
| Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles RD Vaishya, A Mandal, M Gokulgandhi, S Patel, AK Mitra International journal of pharmaceutics 489 (1-2), 237-245, 2015 | 44 | 2015 |
| Thermosensitive hydrogel-based drug delivery system for sustained drug release P Patel, A Mandal, V Gote, D Pal, AK Mitra Journal of Polymer Research 26, 1-11, 2019 | 39 | 2019 |
| Clinical Translation of Choline and Geranic Acid Deep Eutectic Solvent J Ko, A Mandal, S Dhawan, M Shevachman, S Mitragotri, N Joshi Bioengineering & Translational Medicine, e10191, 2020 | 37 | 2020 |
| Self-assembling topical nanomicellar formulation to improve curcumin absorption across ocular tissues M Alshamrani, S Sikder, F Coulibaly, A Mandal, D Pal, AK Mitra Aaps Pharmscitech 20, 1-16, 2019 | 36 | 2019 |
| Design of lipophilic prodrugs to improve drug delivery and efficacy A Mandal, M Patel, Y Sheng, A K Mitra Current drug targets 17 (15), 1773-1798, 2016 | 28 | 2016 |
| Transporter effects on cell permeability in drug delivery A Mandal, V Agrahari, V Khurana, D Pal, AK Mitra Expert opinion on drug delivery 14 (3), 385-401, 2017 | 25 | 2017 |
Samir MitragotriHarvard University, Wyss Institute, UC Santa Barbara, MIT在 g.harvard.edu 的电子邮件经过验证
